Provision of Antioxidant Therapy in Hemodialysis (PATH): A Randomized Clinical Trial

Increased markers of oxidative stress and acute-phase inflammation are prevalent in patients undergoing maintenance hemodialysis therapy (MHD), and are associated with increased mortality and hospitalization rates and decreased erythropoietin responsiveness. No adequately powered studies have examin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Himmelfarb, Jonathan, Ikizler, T. Alp, Ellis, Charles, Wu, Pingsheng, Shintani, Ayumi, Dalal, Sanjay, Kaplan, Mark, Chonchol, Michel, Hakim, Raymond M.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Nephrology 2014
Matèries:
Clinical Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3935590/
https://ncbi.nlm.nih.gov/pubmed/24371300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2013050545
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars